Lidocaine is chemically known as acetamide, 2- (diethylamino) -n - (2, 6-dimethyl phenyl), octanol at pH 7.4;Moisture ratio for 43, lidocaine transdermal patch is suitable for adults and adolescents 12 years of age or temporary pain relief including 5% lidocaine transdermal patches, 1.8% lidocaine transdermal patches, 4% lidocaine transdermal patches containing 5%, 1.8% and 4% respectively of lidocaine adhesive materials, the material paste on nonwoven polyester felt backing, and covered with polyethylene terephthalate (PET) film stripping gasket, before the break on the skin, to remove off lining.
This report contains market size and forecasts of Lidocaine Transdermal Patch in global, including the following market information:
Global Lidocaine Transdermal Patch Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Lidocaine Transdermal Patch Market Sales, 2017-2022, 2023-2028, (M Pcs)
Global top five Lidocaine Transdermal Patch companies in 2021 (%)
The global Lidocaine Transdermal Patch market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Lidocare 5% Transdermal Patch Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lidocaine Transdermal Patch include Teikoku, Teva Pharmaceutical, Sorrento Therapeutics, Hisamitsu, Endo International, Par Pharmaceutical, Mylan and Tide Pharmaceutical (SINO BIOPHARM), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lidocaine Transdermal Patch manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lidocaine Transdermal Patch Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Lidocaine Transdermal Patch Market Segment Percentages, by Type, 2021 (%)
Lidocare 5% Transdermal Patch
Lidocare 1.80% Transdermal Patch
Lidocare 4% Transdermal Patch
Global Lidocaine Transdermal Patch Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Lidocaine Transdermal Patch Market Segment Percentages, by Application, 2021 (%)
Online Pharmacies
Hospital Pharmacies
Clinic
Monomer Pharmacies
Chain Pharmacies
Other
Global Lidocaine Transdermal Patch Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)
Global Lidocaine Transdermal Patch Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lidocaine Transdermal Patch revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Lidocaine Transdermal Patch revenues share in global market, 2021 (%)
Key companies Lidocaine Transdermal Patch sales in global market, 2017-2022 (Estimated), (M Pcs)
Key companies Lidocaine Transdermal Patch sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teikoku
Teva Pharmaceutical
Sorrento Therapeutics
Hisamitsu
Endo International
Par Pharmaceutical
Mylan
Tide Pharmaceutical (SINO BIOPHARM)